Survival benefit associated with screening of patients at elevated risk for pancreatic cancer.
William J KaneKathleen R HadenElizabeth N MartinVanessa M ShamiAndrew Y WangDaniel S StrandSara J AdairSarbajeet NagdasAllan TsungVictor M ZaydfudimReid B AdamsTodd W BauerPublished in: Journal of surgical oncology (2024)
Patients at increased risk for PDAC and followed with guideline-based screening exhibited downstaging of disease and improved survival from PDAC in comparison to patients who were not screened.
Keyphrases